Search - tctmd.com

Displaying 1 - 20 of 134

Sort: Relevancy | Date

News Daily News

Previewing 30-Year ASCVD Risk May Open Door to Earlier Treatment

Yael L. Maxwell

January 21, 2026

News Daily News

Year in Review: Top Prevention Stories of 2025

Michael O'Riordan

December 24, 2025

News Daily News

Pediatric Hypertension On the Rise Globally

Todd Neale

November 28, 2025

News Daily News

Risk Factors Present in Nearly All Patients Who Develop CVD

Michael O'Riordan

October 02, 2025

News Daily News

Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s

Michael O'Riordan

September 18, 2025

News Daily News

Half of Patients Stop Semaglutide for Weight Loss by 1 Year

Todd Neale

September 18, 2025

News Opinion CV Team Dispatch

August 2025 Dispatch for the CV Team

L.A. McKeown

August 22, 2025

News Daily News

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Michael O'Riordan

August 01, 2025

News Daily News

PREVENT Risk Calculator’s Accuracy Varies by Healthcare System, Patient Factors

Michael O'Riordan

July 18, 2025

News Daily News

Majority of US Adults Have High Long-term Risk of CVD: NHANES

Michael O'Riordan

June 13, 2025

App-Based Support Aids Weight Loss With Semaglutide, Studies Show

Michael O'Riordan

May 13, 2025

News Daily News

Access to GLP-1 Drugs Unequal for US Patients With Obesity

Caitlin E. Cox

May 01, 2025

News Daily News

US Football Fans Are Flooded With Ads for Unhealthy Foods

Michael O'Riordan

January 30, 2025

News Opinion CV Team Dispatch

January 2025 Dispatch for the CV Team

L.A. McKeown

January 24, 2025

News Daily News

Misleading Statements Common in Online Ads for Compounded GLP-1s

L.A. McKeown

January 20, 2025

SUMMIT: Tirzepatide ‘Huge Win’ for HFpEF Patients With Obesity

News Conference News AHA 2024

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

Michael O'Riordan

November 16, 2024

News Daily News

Rural Counties Bore Brunt of Worsening CV Mortality During Pandemic

Yael L. Maxwell

November 15, 2024

News Daily News

Many Patients Quit Taking GLP-1 Drugs: Understanding Why Is Key

Todd Neale

November 13, 2024

News Features

Can ‘Body Roundness Index’ Replace BMI? That Depends, Say Experts

Michael O'Riordan

October 21, 2024

News Daily News

Time-Restricted Eating Tightens Glycemic Control in Patients With Metabolic Syndrome

Caitlin E. Cox

October 04, 2024

Advertisement

Previewing 30-Year ASCVD Risk May Open Door to Earlier Treatment

Year in Review: Top Prevention Stories of 2025

Pediatric Hypertension On the Rise Globally

Risk Factors Present in Nearly All Patients Who Develop CVD

Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s

Half of Patients Stop Semaglutide for Weight Loss by 1 Year

August 2025 Dispatch for the CV Team

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

PREVENT Risk Calculator’s Accuracy Varies by Healthcare System, Patient Factors

Majority of US Adults Have High Long-term Risk of CVD: NHANES

App-Based Support Aids Weight Loss With Semaglutide, Studies Show

Access to GLP-1 Drugs Unequal for US Patients With Obesity

US Football Fans Are Flooded With Ads for Unhealthy Foods

January 2025 Dispatch for the CV Team

Misleading Statements Common in Online Ads for Compounded GLP-1s

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

Rural Counties Bore Brunt of Worsening CV Mortality During Pandemic

Many Patients Quit Taking GLP-1 Drugs: Understanding Why Is Key

Can ‘Body Roundness Index’ Replace BMI? That Depends, Say Experts

Time-Restricted Eating Tightens Glycemic Control in Patients With Metabolic Syndrome

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content